Manage episode 292118111 series 1397179
Contributor: Donald Stader, MD
- Opioids target kappa and NMDA receptors that can lead to central nervous system sensitization and therefore increased pain
- For patients with opioid-induced hyperalgesia (OIH), oral ketamine (25-50 mg) can be used to treat their pain as it targets the NMDA receptor
- Other treatments is IV magnesium, NSAIDs, tylenol, and clonidine
- Buprenorphine and methadone are options for chronic pain management in the setting of OIH
Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145-161.
Summarized by John Spartz, MS3 | Edited by Erik Verzemnieks, MD
The Emergency Medical Minute is excited to announce that we are now offering AMA PRA Category 1 credits™ via online course modules. To access these and for more information, visit our website at www.emergencymedicalminute.com/cme-courses/ and create an account.